2021年获得中国科学院大学生物化学与分子生物学博士学位，后于中国科学院深圳先进技术研究院进行博士后研究，现任中国科学院深圳先进技术研究院医药所癌症免疫研究中心副研究员。获得“鹏程孔雀计划”特聘岗位C类人才支持，主持国家自然科学基金青年项目、中国科学院广州分院院长青年人才（培优）项目。研究方向为天然来源靶向药物的抗肿瘤机制研究，共发表SCI论文10篇，其中以第一/共一作者发表5篇，包括Nature Chemical Biology，Chemical Communications，ACS Pharmacology & Translational Science等TOP期刊，并于Nature Nanotechnology，Journal of the American Chemical Society等杂志上参与发表多篇论文。申请中国发明专利4项。
天然产物抗肿瘤机制，基于自噬的靶蛋白降解策略，靶向线粒体的抗肿瘤免疫机制研究等
1. Binghua Cheng; Meiqing Li; Jiwei Zheng; Jiaming Liang; Yanyan Li; Ruijing Liang; Hui Tian; Zeyu Zhou; Li Ding; Jian Ren; Wenli Shi; Wenjie Zhou; Hailiang Hu; Long Meng; Ke Liu; Lintao Cai; Ximing Shao; Lijing Fang; Hongchang Li. Chemically engineered antibodies for autophagy-based receptor degradation, Nature Chemical Biology,2025,https://doi.org/10.1038/s41589-024-01803-1
2. Meiqing Li; Ximing Shao; Chunlei Wu; Danyi Lu; Ke Liu; Wei Wang; Jiakai Liu; Hongchang Li; Wu Su; Lijing Fang ; Chlorotoxin-derived bicyclic peptides for targeted imaging of glioblastomas, Chemical Communications, 2020, 56(66): 9537-9540
3. Meiqing Li; Danyi Lu; Yulian Cheng; Chunlei Wu; Jianchao Zhang; Wenli Shi; Zhihao Ding; Yanyan Li; Binghua Cheng; Xian Lin; Ximing Shao; Hongchang Li; Lijing Fang; Ke Liu; Wu Su ; A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo, Biochemical and Biophysical Research Communications, 2021, 571: 167-173
4. Ke Liu; Rongfeng Zou; Wenqiang Cui; Meiqing Li; Xueying Wang; Junlin Dong; Hongchun Li; Hongpei Li; Peihui Wang; Ximing Shao; Wu Su; H. C. Stephen Chan; Hongchang Li; Shuguang Yuan ; Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2, ACS Pharmacology & Translational Science, 2020, 3(6): 1361-1370
5. Ximing Shao; Zhihao Ding; Wenhua Zhou; Yanyan Li; Zhibin Li; Haodong Cui; Xian Lin; Guoli Cao; Binghua Cheng; Haiyan Sun; Meiqing Li; Ke Liu; Danyi Lu; Shengyong Geng; Wenli Shi; Guofang Zhang; Qingle Song; Liang Chen; Guocheng Wang; Wu Su; Lintao Cai; Lijing Fang; David Tai Leong; Yang Li; Xue-Feng Yu; Hongchang Li ; Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase, Nature Nanotechnology, 2021, 16(10): 1150-1160
（1）Binghua Cheng; Meiqing Li; Jiwei Zheng; Jiaming Liang; Yanyan Li; Ruijing Liang; Hui Tian; Zeyu Zhou; Li Ding; Jian Ren; Wenli Shi; Wenjie Zhou; Hailiang Hu; Long Meng; Ke Liu; Lintao Cai; Ximing Shao; Lijing Fang; Hongchang Li. Chemically engineered antibodies for autophagy-based receptor degradation, Nature Chemical Biology,2025,https://doi.org/10.1038/s41589-024-01803-1（2）Meiqing Li; Ximing Shao; Chunlei Wu; Danyi Lu; Ke Liu; Wei Wang; Jiakai Liu; Hongchang Li; Wu Su; Lijing Fang ; Chlorotoxin-derived bicyclic peptides for targeted imaging of glioblastomas, Chemical Communications, 2020, 56(66): 9537-9540 （3）Meiqing Li; Danyi Lu; Yulian Cheng; Chunlei Wu; Jianchao Zhang; Wenli Shi; Zhihao Ding; Yanyan Li; Binghua Cheng; Xian Lin; Ximing Shao; Hongchang Li; Lijing Fang; Ke Liu; Wu Su ; A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo, Biochemical and Biophysical Research Communications, 2021, 571: 167-173 （4）Ke Liu; Rongfeng Zou; Wenqiang Cui; Meiqing Li; Xueying Wang; Junlin Dong; Hongchun Li; Hongpei Li; Peihui Wang; Ximing Shao; Wu Su; H. C. Stephen Chan; Hongchang Li; Shuguang Yuan ; Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2, ACS Pharmacology & Translational Science, 2020, 3(6): 1361-1370 （5）Ximing Shao; Zhihao Ding; Wenhua Zhou; Yanyan Li; Zhibin Li; Haodong Cui; Xian Lin; Guoli Cao; Binghua Cheng; Haiyan Sun; Meiqing Li; Ke Liu; Danyi Lu; Shengyong Geng; Wenli Shi; Guofang Zhang; Qingle Song; Liang Chen; Guocheng Wang; Wu Su; Lintao Cai; Lijing Fang; David Tai Leong; Yang Li; Xue-Feng Yu; Hongchang Li ; Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase, Nature Nanotechnology, 2021, 16(10): 1150-1160